Evidence map›Paper›PMID 40167910›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Monitoring Cerebrospinal Fluid Inflammatory Mediators by Olink Target 48 Cytokine Panel.

Fabricio Zambom-Ferraresi, Fabiola Zambom-Ferraresi, Maite Izco, Nicolás Martínez-Velilla, Leire Extramiana, Joaquín Fernández-Irigoyen, Enrique Santamaría, Adrían Llamas-Urbano, Yasin Hanaee, Julio M Martinez-Moreno and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fabricio Zambom-FerraresiDepartment of Geriatric Medicine, Hospital Universitario de Navarra (HUN), Navarrabiomed, Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Fabiola Zambom-FerraresiDepartment of Geriatric Medicine, Hospital Universitario de Navarra (HUN), Navarrabiomed, Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Maite IzcoDepartment of Geriatric Medicine, Hospital Universitario de Navarra (HUN), Navarrabiomed, Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Nicolás Martínez-VelillaDepartment of Geriatric Medicine, Hospital Universitario de Navarra (HUN), Navarrabiomed, Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Leire ExtramianaClinical Neuroproteomics Laboratory, Proteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Joaquín Fernández-IrigoyenClinical Neuroproteomics Laboratory, Proteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Enrique SantamaríaClinical Neuroproteomics Laboratory, Proteomics Unit, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Adrían Llamas-UrbanoCobiomic Bioscience. EBT University of Cordoba/IMIBIC, Cordoba, Spain.
Yasin HanaeeCobiomic Bioscience. EBT University of Cordoba/IMIBIC, Cordoba, Spain.
Julio M Martinez-MorenoCobiomic Bioscience. EBT University of Cordoba/IMIBIC, Cordoba, Spain.
Nuria BarbarrojaCobiomic Bioscience. EBT University of Cordoba/IMIBIC, Cordoba, Spain.
Carlos Pérez-SánchezCobiomic Bioscience. EBT University of Cordoba/IMIBIC, Cordoba, Spain. carlos@cobiomic.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis and monitoring of neurological disorders are challenging due to their complexity and the difficulty of obtaining samples of damaged tissue while the patient is alive. Cerebrospinal fluid (CSF) is an excellent biofluid for conducting diagnostic and monitoring studies because it is in direct contact with the brain, allowing for the analysis of secreted proteins and peptides associated with various neurological disorders.The Proximity Extension Assay, which combines antibodies with oligonucleotides to detect proteins via qPCR, is revolutionizing the field of biomarker identification. The Olink Target 48 Cytokine Panel is an optimal tool for evaluating the inflammatory profile of CSF samples, requiring only one microliter. The workflow involves incubation with antibody-linked oligonucleotides, extension, amplification through a PCR assay, and detection using microfluidic qPCR, enabling precise and accurate quantification of cytokine levels in pg/mL. This approach offers valuable insights into inflammatory processes within the CSF, serving as a robust tool for studying and understanding inflammation in neurological contexts.

Indexed as

CytokinesInflammation MediatorsBiomarkersHumansInflammationReal-Time Polymerase Chain ReactionBiomarkersCytokinesInflammation MediatorsCSFCytokinesInflammationNeurobiologyProximity extension assay

Identifiers

PMID40167910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.